Breast cancer in men in Cote d'Or (France): epidemiological characteristics, treatments and prognostic factors
Authors:
- T.S. DabakuyoTDT.S. Dabakuyo
- M.-L. PoillotMPM.-L. Poillot
- P. ArveuxPAP. Arveux
- 30 May 2012
- journal article
- research article
- Published by Hindawi Limited in European Journal of Cancer Care
- Vol. 21 (6) , 809-816
Abstract
Breast cancer in men is rare, and clinical trials are thus not feasible. This study aimed to describe the epidemiological characteristics, treatment and prognostic factors of breast cancer in men. A population-based study was performed using data from the Cote d'Or breast and gynaecological cancer registry. Data on male breast cancer diagnosed from 1982 to 2008 were provided. Relative survival rates were estimated at 5 years according to the characteristics of the patient and tumour, and treatment. Prognostic factors of survival in men with breast cancer were identified using a generalised linear model. Seventy-five men with invasive breast cancer were registered. Mean age at diagnosis was 66 years. The use of adjuvant chemotherapy (P= 0.013) and hormone therapy (P < 0.0001) increased over time. Relative survival rate at 5 years was 69% for the whole population. Analysis of relative survival according to the treatment showed that survival was longer for patients treated with surgery + radiotherapy + hormone therapy: 89% at 5 years. Scarff, Bloom and Richardson grade was independent prognostic factor of survival. Male breast cancer is a rare disease with a poor prognosis, and diagnosis is often made at an advanced stage. Early diagnosis and better knowledge of the disease would certainly lead to improvements in the prognosis.Keywords
This publication has 27 references indexed in Scilit:
- Breast cancer in men in the United StatesCancer, 2010
- Male breast cancerCritical Reviews in Oncology/Hematology, 2010
- Population-based study of breast cancer survival in Cote d’Or (France): prognostic factors and relative survivalAnnals of Oncology, 2007
- Invasive carcinomas of the male breast: a morphologic study of the distribution of histologic subtypes and metastatic patterns in 778 casesVirchows Archiv, 2006
- Adjuvant systemic therapy for male breast carcinomaCancer, 2005
- Is Male Breast Cancer Similar or Different than Female Breast Cancer?Breast Cancer Research and Treatment, 2004
- Regression models for relative survivalStatistics in Medicine, 2003
- Male breast cancer: a 22-year experienceEuropean Journal of Surgical Oncology, 1998
- A review of the management of the male breast carcinoma based on an analysis of 420 treated casesThe Breast, 1996
- Male breast cancer: Results of the treatments and prognostic factors in 397 casesEuropean Journal of Cancer, 1995